New and disturbing concerns about fake GLP-1 drugs are cited in a letter sent to the FDA by Tennessee officials, including Sen. Marsha Blackburn.

The US diabetes market presents a substantial opportunity for Biocon Biologics, with 38.4 million people living with diabetes ...

Health leaders, policymakers and development partners across Africa have renewed commitment to accelerate the implementation ...

Cardiologist Recommends Four Simple Changes To Slash Cholesterol Better Than Statins As Anshula Kapoor Announces Engagement, ...

Study design. This prospective, randomized, controlled, parallel-group study compared the use of pen devices with conventional vials and syringes for the administration of insulin in hospitalized ...

In this study, significantly more patients in the insulin pen group prepared and self-injected at least one dose of insulin compared with the vial and syringe group. Patients with newly diagnosed ...

The report includes historical data from 2023 to 2024 and forecasts until 2033. The insulin pen market in the United States has experienced remarkable growth over the last few years.

How TIME and Statista Determined the World's Most Sustainable Companies of 2025 In the fight against climate change, companies are navigating ...

Diabetic woman no longer needs insulin after single stem cell treatment — why it’s not given to everyone with diabetes ...

Breakthrough studies at the ADA highlight VX-880 stem cell therapy, drastically reducing insulin dependency for type 1 diabetes patients.